These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25538279)

  • 21. [Rhinorrhea as side-effect of spironolactone].
    Ayerbe García-Monzón L; Herrero Hernández S; González López E; Alcaraz Borrajo M
    Aten Primaria; 2004 Feb; 33(3):164. PubMed ID: 14987504
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.
    Schindler TH; Facta AD; Prior JO; Cadenas J; Hsueh WA; Quinones MJ; Schelbert HR
    Heart; 2007 Mar; 93(3):345-9. PubMed ID: 16940388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure.
    Eng M; Bansal S
    Int J Cardiol; 2014 Jan; 170(3):e68-9. PubMed ID: 24268982
    [No Abstract]   [Full Text] [Related]  

  • 24. [A comparative evaluation of the effect of glurenorm and sulfonylurea preparations on the intravascular microcirculatory indices in type-II diabetes mellitus].
    Kakhnovskiĭ IM; Koroleva TV; Zakharchenko VN; Larionov SN
    Probl Endokrinol (Mosk); 1993; 39(2):7-9. PubMed ID: 8016059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor (PREDICT): study rationale and design. A randomized multicenter clinical trial using intracoronary multimodal physiology.
    Cerrato E; Quirós A; Echavarría-Pinto M; Mejia-Renteria H; Aldazabal A; Ryan N; Gonzalo N; Jimenez-Quevedo P; Nombela-Franco L; Salinas P; Núñez-Gil IJ; Rumoroso JR; Fernández-Ortiz A; Macaya C; Escaned J
    Cardiovasc Diabetol; 2017 May; 16(1):68. PubMed ID: 28526024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of an aldosterone receptor blocker eplerenone in high risk survivors of acute myocardial infarction with signs of heart failure: results of EPHESUS].
    Trifonov IR
    Kardiologiia; 2003; 43(6):71-2. PubMed ID: 12974260
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.
    Lainscak M; Pelliccia F; Rosano G; Vitale C; Schiariti M; Greco C; Speziale G; Gaudio C
    Int J Cardiol; 2015 Dec; 200():25-9. PubMed ID: 26404748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
    Joshi MS; Williams D; Horlock D; Samarasinghe T; Andrews KL; Jefferis AM; Berger PJ; Chin-Dusting JP; Kaye DM
    Diab Vasc Dis Res; 2015 May; 12(3):208-16. PubMed ID: 25767181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus.
    Sezer M; Kocaaga M; Aslanger E; Atici A; Demirkiran A; Bugra Z; Umman S; Umman B
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eplerenone reduces morbidity and mortality after acute MI.
    Cardiovasc J S Afr; 2006; 17(5):280. PubMed ID: 17117244
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site.
    Zhao M; Rodríguez-Villagra E; Kowalczuk L; Le Normand M; Berdugo M; Levy-Boukris R; El Zaoui I; Kaufmann B; Gurny R; Bravo-Osuna I; Molina-Martínez IT; Herrero-Vanrell R; Behar-Cohen F
    J Control Release; 2017 Nov; 266():187-197. PubMed ID: 28947395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa).
    Hammer F; Krane V; Störk S; Röser C; Hofmann K; Pollak N; Allolio B; Wanner C
    Nephrol Dial Transplant; 2014 Feb; 29(2):400-5. PubMed ID: 24166468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of antiaggregants on the course of diabetic microangiopathy].
    Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
    Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Which patient needs an aldosterone antagonist?].
    Schultheiss
    MMW Fortschr Med; 2003 Apr; 145(16):6. PubMed ID: 14606390
    [No Abstract]   [Full Text] [Related]  

  • 35. [Normoaldosterone spironolactone sensitive hypertension--a case report].
    Krysiak R; Okopień B; Herman ZS
    Pol Arch Med Wewn; 2005 Oct; 114(4):978-81. PubMed ID: 16789524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eplerenone for treatment of heart failure].
    Yoshimura M
    Nihon Rinsho; 2007 May; 65 Suppl 5():153-8. PubMed ID: 17569313
    [No Abstract]   [Full Text] [Related]  

  • 37. Intensive glucose lowering treatment in type 2 diabetes.
    Preiss D; Ray KK
    BMJ; 2011 Jul; 343():d4243. PubMed ID: 21791496
    [No Abstract]   [Full Text] [Related]  

  • 38. [Deficiency of 11beta-hydroxysteroid dehydrogenase type 2 (syndrome of apparent mineralocorticoid excess)].
    Mune T
    Nihon Rinsho; 2006 May; Suppl 1():651-4. PubMed ID: 16776240
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
    Hayashi M
    J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.